*** Conﬁdential Treatment Requested and the Redacted Material has been separately ﬁled with the Commission.
(c) Valid Issuance of Shares . The Warrant Shares have been duly reserved for issuance and, upon issuance
in accordance with the terms of this Warrant, will be duly authorized, validly issued, fully paid and nonassessable and issued free and
clear of any lien, encumbrance, security interest, pledge, mortgage, hypothecation, charge, adverse claim, title retention agreement of any
nature or kind, or other encumbrance (except any applicable securities law restrictions). The offer, sale and issuance of this Warrant and
the issuance of the Warrant Shares upon exercise hereof (i) are not subject to and will not give rise to any preemptive rights or rights of
first refusal with respect thereto and (ii) are and will be in compliance with all applicable federal and state securities laws.
((1) Governmental Consents and Filings: . No consent, approval, order, waiver, exemption or authorization of,
registration, declaration, filing or qualification with, certification, notice, application or report to, or expiration of any waiting period
applicable to, any governmental authority, self—regulatory organization (including the NASDAQ Stock Market or any other applicable
national securities exchange) or any other third party is required on the part of the Company in connection with the execution and delivery
of this Warrant and the Registration Rights Agreement or the offer, sale and issuance of this Warrant or, except as provided in Sections
3(e)(i) and 3(e)(ii), the issuance of the Warrant Shares upon exercise hereof.
(e) Complianc,e,with,Laws,and,cheriInstruments,.
(i) Neither the Company nor any of its subsidiaries is in violation of or default under, and from
December 31, 2013 through the Issue Date has not received any notices of Violation or default with respect to, (A) any provisions of its
certificate of incorporation, bylaws or other organizational documents, (B) any instrument, judgment, order, writ or decree of any court or
governmental authority applicable to the Company or any of its subsidiaries, or (C) any note, indenture, mortgage, lease, agreement,
instrument or other contract to which it is a party or by which it is bound, except in the case of clauses (B) and (C) for such violations or
defaults as would not, individually or in the aggregate, have a Material Adverse Effect.
(ii) Neither the Company nor any of its subsidiaries is in violation of, and the operation of the
Company’s and its subsidiaries’ businesses as now conducted does not violate, any provision of any federal, state, local or foreign law,
statute, rule or regulation applicable to the Company or its subsidiaries, except for such violations as would not, individually or in the
aggregate, have a Material Adverse Effect.
(iii) The execution, delivery and, subject to Sections 3(e)(i) and 3(e)(ii), performance of this
Warrant and the Registration Rights Agreement by the Company and the offer, sale and issuance of this Warrant and, subject to Sections
3(e)(i) and 3(e)(ii), the issuance of the Warrant Shares upon exercise hereof do not and will not conﬂict with, result in a Violation of or
default under (with or without the passage of time and/or the giving of notice), or give rise to a right of termination, cancellation or
acceleration of any obligation or to a loss of a material benefit under, (A) any provisions of the Company’s or any of its subsidiaries’
certificate of incorporation, bylaws or other organizational documents, (B) any instrument, judgment, order, writ or decree of any court or
governmental authority applicable to the Company or any of its subsidiaries, or (C) any note, indenture, mortgage, lease, agreement,
instrument or other contract to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries